Jan 21, 2021
Scientific Advisory Board Expanded with Additions of Global Medical Pioneers and Distinguished Thought Leaders HINGHAM, Mass. , Jan. 21, 2021 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) continues to enhance its thought leadership capabilities with the addition of several new Scientific
Jan 14, 2021
Results Validate Findings of Initial Study; End Points Achieved with No Intraoperative Adverse Events Management Presenting at Needham Growth Conference Today at 2:00pm ET HINGHAM, Mass. , Jan. 14, 2021 (GLOBE NEWSWIRE) -- The continued progression of Microbot Medical Inc.’s (Nasdaq: MBOT)
Jan 11, 2021
HINGHAM, Mass. , Jan. 11, 2021 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq CM: MBOT) has concluded 2020 with the achievement of several operating and developmental milestones. The Company believes it is well positioned to leverage and capitalize upon this momentum through 2021, with plans to
Jan 07, 2021
HINGHAM, Mass. , Jan. 07, 2021 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), announced that Harel Gadot , CEO, President and Chief Executive Officer, will be presenting virtually at two upcoming investor conferences. Mr. Gadot will review the Company’s recent achievements, current
Nov 17, 2020
HINGHAM, Mass. , Nov. 17, 2020 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) announced that it has received patents in multiple jurisdictions, further demonstrating the Company’s continued execution of expanding and protecting its Intellectual Property (IP) portfolio.
Nov 09, 2020
Webcast to be Held on Thursday November 12 th at 2:00pm ET HINGHAM, Mass. , Nov. 09, 2020 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) announced that Harel Gadot , the Company’s CEO, President and Chairman, will be providing an overview of the Company, as well as recent progress and
Oct 07, 2020
HINGHAM, Mass. , Oct. 07, 2020 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for patent application No. 15/592,227, which pertains to a device for reducing dialysis shunt stenosis.
Aug 20, 2020
Webinar to be Held on Wednesday August 26th at 11am ET HINGHAM, Mass. , Aug. 20, 2020 (GLOBE NEWSWIRE) -- Following its participation at the Needham Virtual Med Tech & Diagnostic conference, as well as the overwhelming interest generated since its recent announcement which included the outcome of a
Aug 17, 2020
World’s First Fully Disposable Surgical Robot Achieved all Endpoints with No Intraoperative Adverse Events LIBERTY™ Robotic System being remotely operated LIBERTY™ Robotic System Remotely Performed Procedures have the Potential to Reduce Radiation Exposure, Physical Strain and Cross Contamination

Displaying 91 - 99 of 152

Search Investor Relations